and menstrual irregularities in women, as reproductive hormones are sensitive to energy availability
45 Remarkably, the recent SELECT trial proved the cardiovascular efficacy of subcutaneous semaglutide in reducing the primary cardiovascular composite endpoint (death from cardiovascular causes, non-fatal MI or non-fatal stroke) in both overweight and obese patients with established atherosclerotic CVD
Compounding is the practice where a licensed pharmacist combines or alters ingredients to create a medication tailored to the needs of an individual patient
Side effects such as nausea and headaches, which are more common with GLP-1 therapies than with Metformin, also contribute to early discontinuation
Both compounded and brand-name GLP-1 medications are available in multi-dose vials
Visual worsening was neither associated with the treatment group nor with the papilledema degree or visual impairment at baseline (Supplementary Table 4)